| Literature DB >> 33478057 |
Olga Kulikova1, Andreas Brodehl2, Anna Kiseleva1, Roman Myasnikov1, Alexey Meshkov1, Caroline Stanasiuk2, Anna Gärtner2, Mikhail Divashuk1,3, Evgeniia Sotnikova1, Sergey Koretskiy1, Maria Kharlap1, Viktoria Kozlova1, Elena Mershina4, Polina Pilus4, Valentin Sinitsyn4, Hendrik Milting2, Sergey Boytsov5, Oxana Drapkina1.
Abstract
Here, we present a small Russian family, where the index patient received a diagnosis of left-ventricular non-compaction cardiomyopathy (LVNC) in combination with a skeletal myopathy. Clinical follow-up analysis revealed a LVNC phenotype also in her son. Therefore, we applied a broad next-generation sequencing gene panel approach for the identification of the underlying mutation. Interestingly, DES-p.A337P was identified in the genomes of both patients, whereas only the index patient carried DSP-p.L1348X. DES encodes the muscle-specific intermediate filament protein desmin and DSP encodes desmoplakin, which is a cytolinker protein connecting desmosomes with the intermediate filaments. Because the majority of DES mutations cause severe filament assembly defects and because this mutation was found in both affected patients, we analyzed this DES mutation in vitro by cell transfection experiments in combination with confocal microscopy. Of note, desmin-p.A337P forms cytoplasmic aggregates in transfected SW-13 cells and in cardiomyocytes derived from induced pluripotent stem cells underlining its pathogenicity. In conclusion, we suggest including the DES gene in the genetic analysis for LVNC patients in the future, especially if clinical involvement of the skeletal muscle is present.Entities:
Keywords: DES; DSP; cardiomyopathy; cardiovascular genetics; desmin; desminopathy; desmoplakin; dilated cardiomyopathy; left-ventricular non-compaction cardiomyopathy
Mesh:
Substances:
Year: 2021 PMID: 33478057 PMCID: PMC7835827 DOI: 10.3390/genes12010121
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096